Trinity Biotech plc
TRIB
$0.34
$0.00-1.43%
NASDAQ
| 12/31/2024 | 12/31/2024 | 09/30/2024 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -256.29% | -256.27% | 29.57% | -12.68% | 7.84% |
| Total Depreciation and Amortization | -228.09% | -28.76% | 290.85% | -74.60% | 185.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 456.85% | 456.72% | -36.89% | 4.24% | -10.34% |
| Change in Net Operating Assets | 441.70% | 441.65% | -212.31% | 988.89% | 106.90% |
| Cash from Operations | 192.47% | 192.44% | -229.45% | 170.86% | 134.99% |
| Capital Expenditure | -42.73% | -42.73% | -52.78% | -47.98% | -124.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.77% | 13.80% | 3.33% | 34.00% | 39.51% |
| Cash from Investing | 11.77% | 11.80% | 2.05% | 14.12% | 26.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 1.92% | 1.92% | -12.44% | 12.28% | 98.06% |
| Issuance of Common Stock | -92.36% | -92.34% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 96.63% | 96.58% | -10.86% | 29.86% | 69.10% |
| Cash from Financing | -57.45% | -57.47% | 8.38% | 40.85% | -154.82% |
| Foreign Exchange rate Adjustments | -1,960.00% | -1,940.00% | 104.63% | 118.44% | -16.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 193.94% | 193.94% | -439.65% | 78.87% | -825.40% |